Free Trial
→ Trump's gold order: the announcement they won't put on the front page (From Reagan Gold Group) (Ad)tc pixel Free BFRIW Stock Alerts

Biofrontera (BFRIW) Competitors

Biofrontera logo
$0.03 0.00 (0.00%)
As of 06/3/2026 11:16 AM Eastern
Compare

BFRIW vs. AIMDW, ALVOW, ARAV, ACABW, and CELUW

Should you buy Biofrontera stock or one of its competitors? MarketBeat compares Biofrontera with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Biofrontera include Ainos (AIMDW), Alvotech (ALVOW), Aravive (ARAV), Atlantic Coastal Acquisition Corp. II (ACABW), and Celularity (CELUW). These companies are all part of the "pharmaceutical products" industry.

How does Biofrontera compare to Ainos?

Ainos (NASDAQ:AIMDW) and Biofrontera (NASDAQ:BFRIW) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, earnings, institutional ownership, risk, media sentiment, valuation, profitability and analyst recommendations.

Company Net Margins Return on Equity Return on Assets
AinosN/A N/A N/A
Biofrontera N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ainos$18.11KN/AN/AN/AN/A
Biofrontera$43.20MN/AN/AN/AN/A

In the previous week, Ainos had 1 more articles in the media than Biofrontera. MarketBeat recorded 1 mentions for Ainos and 0 mentions for Biofrontera. Ainos' average media sentiment score of 0.62 beat Biofrontera's score of 0.43 indicating that Ainos is being referred to more favorably in the media.

Company Overall Sentiment
Ainos Positive
Biofrontera Neutral

Summary

Ainos beats Biofrontera on 2 of the 3 factors compared between the two stocks.

How does Biofrontera compare to Alvotech?

Alvotech (NASDAQ:ALVOW) and Biofrontera (NASDAQ:BFRIW) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, analyst recommendations, valuation, profitability, earnings, media sentiment, institutional ownership and risk.

In the previous week, Alvotech's average media sentiment score of 1.44 beat Biofrontera's score of 0.43 indicating that Alvotech is being referred to more favorably in the media.

Company Overall Sentiment
Alvotech Positive
Biofrontera Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Alvotech$586.32MN/AN/AN/AN/A
Biofrontera$43.20MN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
AlvotechN/A N/A N/A
Biofrontera N/A N/A N/A

Summary

Alvotech beats Biofrontera on 2 of the 2 factors compared between the two stocks.

How does Biofrontera compare to Aravive?

Aravive (NASDAQ:ARAV) and Biofrontera (NASDAQ:BFRIW) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, analyst recommendations, valuation, profitability, earnings, media sentiment, institutional ownership and risk.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
AraviveN/AN/AN/A-$0.90N/A
Biofrontera$43.20MN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
AraviveN/A N/A N/A
Biofrontera N/A N/A N/A

In the previous week, Biofrontera's average media sentiment score of 0.43 beat Aravive's score of 0.00 indicating that Biofrontera is being referred to more favorably in the news media.

Company Overall Sentiment
Aravive Neutral
Biofrontera Neutral

35.8% of Aravive shares are owned by institutional investors. 60.4% of Aravive shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Summary

Aravive and Biofrontera tied by winning 2 of the 4 factors compared between the two stocks.

How does Biofrontera compare to Atlantic Coastal Acquisition Corp. II?

Biofrontera (NASDAQ:BFRIW) and Atlantic Coastal Acquisition Corp. II (NASDAQ:ACABW) are both pharmaceutical products companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, media sentiment, valuation, dividends, institutional ownership, analyst recommendations, earnings and profitability.

Company Net Margins Return on Equity Return on Assets
BiofronteraN/A N/A N/A
Atlantic Coastal Acquisition Corp. II N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Biofrontera$43.20MN/AN/AN/AN/A
Atlantic Coastal Acquisition Corp. IIN/AN/AN/AN/AN/A

In the previous week, Biofrontera's average media sentiment score of 0.43 beat Atlantic Coastal Acquisition Corp. II's score of 0.00 indicating that Biofrontera is being referred to more favorably in the media.

Company Overall Sentiment
Biofrontera Neutral
Atlantic Coastal Acquisition Corp. II Neutral

Summary

Biofrontera beats Atlantic Coastal Acquisition Corp. II on 2 of the 2 factors compared between the two stocks.

How does Biofrontera compare to Celularity?

Celularity (NASDAQ:CELUW) and Biofrontera (NASDAQ:BFRIW) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, risk, media sentiment, earnings, institutional ownership, valuation, dividends and profitability.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Celularity$26.55MN/AN/AN/AN/A
Biofrontera$43.20MN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
CelularityN/A N/A N/A
Biofrontera N/A N/A N/A

In the previous week, Celularity had 1 more articles in the media than Biofrontera. MarketBeat recorded 1 mentions for Celularity and 0 mentions for Biofrontera. Celularity's average media sentiment score of 0.76 beat Biofrontera's score of 0.43 indicating that Celularity is being referred to more favorably in the media.

Company Overall Sentiment
Celularity Positive
Biofrontera Neutral

Summary

Celularity beats Biofrontera on 2 of the 3 factors compared between the two stocks.

Get Biofrontera News Delivered to You Automatically

Sign up to receive the latest news and ratings for BFRIW and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BFRIW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BFRIW vs. The Competition

Export
MetricBiofronteraDrug Manufacturers IndustryMedical SectorNASDAQ Exchange
Market CapN/A$2.49B$6.43B$12.45B
Dividend YieldN/A2.95%2.69%5.22%
P/E RatioN/A4.8623.8524.37
Price / SalesN/A1,763.43522.03117.40
Price / CashN/A10.1841.2757.13
Price / BookN/A11.0310.046.75
Net IncomeN/A$20.70B$3.56B$337.03M
7 Day PerformanceN/A0.11%-0.82%0.08%
1 Month PerformanceN/AN/AN/A-1.66%
1 Year PerformanceN/A16.45%28.88%34.01%

Biofrontera Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BFRIW
Biofrontera
N/A$0.03
flat		N/A-77.9%$0.00$43.20MN/A70
AIMDW
Ainos
N/A$0.11
-14.3%		N/A-19.3%$0.00$18.11KN/A40
ALVOW
Alvotech
N/A$0.24
-7.7%		N/A-90.5%$0.00$586.32MN/A4
ARAV
Aravive
N/A$0.04
flat		N/AN/A$0.00N/AN/A20
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.00
flat		N/AN/A$0.00N/AN/A15

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:BFRIW) was last updated on 6/4/2026 by MarketBeat.com Staff.
From Our Partners
"You'll own nothing and be happy" (it's not a theory anymore)
Since 1913, the evidence is clear… Once they force everyone onto CBDCs, there will be no escape. Every tran...
Decentralized Masters | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
How to claim a stake in SpaceX before the June 12 IPO
SpaceX is expected to go public on June 12 - and for the first time, everyday investors may have a way in befo...
Brownstone Research | Sponsoredtc pixel
Trump’s secret China deal
Trump just returned from Beijing with the most powerful business delegation in American history - Elon Musk, J...
Porter & Company | Sponsoredtc pixel
June 4: The day smart money moves (not June 12)
Everyone is watching June 12 - the SpaceX listing date. The real deadline is June 4, when Goldman Sachs, Morga...
Behind the Markets | Sponsoredtc pixel
Giving “2022 pre-ChatGPT” vibes (but 10x bigger)
When ChatGPT launched in 2022, Nvidia surged 1,800% over three years. Now, Nvidia's CEO suggests July 22nd cou...
StocksToTrade | Sponsoredtc pixel
Your $29.97 book is free today
Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...
Profits Run | Sponsoredtc pixel
AI breakthrough hidden inside SpaceX exposed on June 11
On June 11, SpaceX is hosting a major investor event - and growth investor Louis Navellier believes Elon Musk ...
InvestorPlace | Sponsoredtc pixel